Stallworth, S., Stilley, K., Viriyakitja, W., Powers, S., Parish, A., Erkanli, A., & Komisar, J. (2024). 913: EVALUATION OF PHENOBARBITAL DOSING IN HOSPITALIZED PATIENTS WITH ALCOHOL WITHDRAWAL SYNDROME. In Critical Care Medicine (Vol. 52, pp. S428–S428). Ovid Technologies (Wolters Kluwer Health). https://doi.org/10.1097/01.ccm.0001001816.91441.ee

Stallworth, Sara, Kelsey Stilley, Wassamon Viriyakitja, Shelby Powers, Alice Parish, Alaattin Erkanli, and Jonathan Komisar. “913: EVALUATION OF PHENOBARBITAL DOSING IN HOSPITALIZED PATIENTS WITH ALCOHOL WITHDRAWAL SYNDROME.” In Critical Care Medicine, 52:S428–S428. Ovid Technologies (Wolters Kluwer Health), 2024. https://doi.org/10.1097/01.ccm.0001001816.91441.ee.

Stallworth S, Stilley K, Viriyakitja W, Powers S, Parish A, Erkanli A, et al. 913: EVALUATION OF PHENOBARBITAL DOSING IN HOSPITALIZED PATIENTS WITH ALCOHOL WITHDRAWAL SYNDROME. In: Critical Care Medicine. Ovid Technologies (Wolters Kluwer Health); 2024. p. S428–S428.

Stallworth, Sara, et al. “913: EVALUATION OF PHENOBARBITAL DOSING IN HOSPITALIZED PATIENTS WITH ALCOHOL WITHDRAWAL SYNDROME.” Critical Care Medicine, vol. 52, no. 1, Ovid Technologies (Wolters Kluwer Health), 2024, pp. S428–S428. Crossref, doi:10.1097/01.ccm.0001001816.91441.ee.

Stallworth S, Stilley K, Viriyakitja W, Powers S, Parish A, Erkanli A, Komisar J. 913: EVALUATION OF PHENOBARBITAL DOSING IN HOSPITALIZED PATIENTS WITH ALCOHOL WITHDRAWAL SYNDROME. Critical Care Medicine. Ovid Technologies (Wolters Kluwer Health); 2024. p. S428–S428.